News | Magnetic Resonance Imaging (MRI) | January 09, 2020

MR Solutions Grows Support Network

With more than 2,000 sites across the globe, MR Solutions is now present on every continent bar Antarctica

MR Solutions cryogen free preclinical MRI

January 9, 2020 — MR Solutions is continuing to expand its support network as its base of preclinical liquid helium free multimodality MRI systems become the norm in research laboratories across the world.

MR Solutions has multiple distributors in Japan, Korea, Australia and China. In Europe and Russia there are not only multiple distributors but also specialist engineers. In North America MR Solutions has a U.S. sales office, distributors and specialist engineers. South American sites are supported through three distributors.

As well as this growing network of distributors and specialist engineers, MR Solutions’ head office in the UK provides around the clock support through its online links with every installed system. 

With more than 2,000 sites across the globe, which includes spectrometers - the brains of any scanner system - MR Solutions is now present on every continent bar Antarctica.

Fabrice Chaumard, sales director, commented, “We are very conscious that in the rare event of one of our systems requiring a specialist technician on site that assistance should be close by. We will continue to expand our network to ensure we offer best in class support.”

MR Solutions has become the leading force in preclinical scanning through continuous innovation including liquid helium free, high field MRI scanners, solid state clip on PET, ringless detectors and recently a range of state of the art multi-modality CT scanners. MR Solutions remains the only company with an installed base of multi-modality, liquid helium free MRI systems.

All of the 28 models of preclinical scanners share a common animal handling solution so that transfers between different types of scanner is quick and easy.

MR Solutions, based in the UK, has over 30 years’ experience and in excess of 2,000 installations including spectrometer sales across the world. MR Solutions holds the prestigious Queen’s Awards for Enterprise, achieving this for Innovation in 2016 and 2019 and for International Trade in 2017. Its scanners are renowned for their excellence in terms of superior soft tissue contrast and molecular imaging ability.

For more information: www.mrsolutions.com

Related Content

Two magnetic resonance imaging (MRI) findings — joint capsule edema and thickness at the axillary recess, specifically — proved useful in predicting stiff shoulder in patients with rotator cuff tears, according to an ahead-of-print article in the May issue of the American Journal of Roentgenology (AJR)

A: Oblique coronal fat-suppressed T2-weighted MR image shows normal hypointense joint capsule at axillary recess (arrow). Note full-thickness tear of supraspinatus tendon (arrowheads) B: Oblique sagittal proton density MR image shows preserved subcoracoid fat triangle (asterisk). Image courtesy of the American Journal of Roentgenology (AJR)

News | Magnetic Resonance Imaging (MRI) | February 20, 2020
February 20, 2020 — Two ma...
Hyperfine Research, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the world’s first bedside Magnetic Resonance Imaging (MRI) system

Hyperfine's point-of-care MRI wheels directly to the patient’s bedside, plugs into a standard electrical wall outlet, and is controlled via a wireless tablet. Photo courtesy of Business Wire

News | Magnetic Resonance Imaging (MRI) | February 12, 2020
February 12, 2020 — Hyperfine Research, Inc. announced that i
The magnetic resonance imaging (MRI) contrast agents market is expected to grow rapidly

Image courtesy of GE Healthcare

News | Magnetic Resonance Imaging (MRI) | February 11, 2020
February 11, 2020 — The magnetic resonance imaging (MRI) contrast agents market is expected to grow rapidly in the fo
Gadolinium-based contrast agents

UT Dallas faculty members who collaborated with Dr. Jeremiah Gassensmith (center, back), associate professor of chemistry and biochemistry, include Dr. Lloyd Lumata (left, back), assistant professor of physics, and Dr. Steven Nielsen, associate professor of chemistry. Chemistry graduate students in Gassensmith’s lab include (from left, front) Oliva Brohlin, Arezoo Shahrivarkevishahi and Laurel Hagge.

News | Contrast Media | February 06, 2020
February 6, 2020 — University of Texas at Dallas researchers
Qynapse, a medical technology company, announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its QyScore software
News | Information Technology | February 04, 2020
February 4, 2020 — Qynapse, a medical technology company, anno
RSNA 2019

RSNA 2019

Feature | Radiology Imaging | January 31, 2020 | By Greg Freiherr
The founder of Gonzo journalism thought
This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma

This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma. The quarter dose image on the left was obtained after the administration of 4 ml of MultiHance. Subsequently, an additional 12 ml of MultiHance was administered and the cumulative full dose image in the center was obtained. The image on the right was rendered following artificial intelligence processing of the 4 ml image using eGad genetic algorithms. This image has the quality of triple dose gadolinium even though only one quarter dose gadolinium was given.

Feature | Contrast Media Injectors | January 30, 2020 | By Matthew Kuhn, M.D., FACR
Gadolinium-based contrast agents (...
The researchers used high resolution cross-sectional imaging with CT or MRI to assess 225 men with abdominal aortic aneurysm. Follow-up lasted, on average, more than three years.  Slightly more than half of patients had an intraluminal thrombus. The aneurysms of those with intraluminal thrombus were larger at baseline and grew by a rate of 2 mm per year, twice as fast as the 1 mm per year growth rate in people without intraluminal thrombus.
News | Computed Tomography (CT) | January 29, 2020
January 29, 2020 – The presence of a blood clot on the wall of the aorta in people with...
Gadolinium based contrast dye in brain MRI

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

News | Contrast Media | January 17, 2020
January 17, 2020 — Bracco Diagnostics Inc., the U.